Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/handle/10553/72737
| Title: | Evaluation of TMB in KEYNOTE-189: Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy for Nonsquamous NSCLC | Authors: | Garassino, M. Rodriguez-Abreu, D. Gadgeel, S. Esteban, E. Felip, E. Speranza, G. Reck, M. Hui, R. Boyer, M. Cristescu, R. Aurora-Garg, D. Albright, A. Loboda, A. Kobie, J. Lunceford, J. Ayers, M. Lubiniecki, G. Piperdi, B. Pietanza, M. C. Garon, E. |
UNESCO Clasification: | 320101 Oncología | Keywords: | Immunotherapy Tmb Chemotherapy |
Issue Date: | 2019 | Journal: | Journal of Thoracic Oncology | URI: | https://accedacris.ulpgc.es/handle/10553/72737 | ISSN: | 1556-0864 | DOI: | 10.1016/j.jtho.2019.08.427 | Source: | Journal Of Thoracic Oncology [ISSN 1556-0864],v. 14 (10) sup. S, p. S216-S217, (Octubre 2019) |
| Appears in Collections: | Actas de congresos |
WEB OF SCIENCETM
Citations
73
checked on Jun 8, 2025
Page view(s)
140
checked on May 31, 2025
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.